^
    Apply
    Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML) (NCT05682170)
    Phase 1/2
    K-Group Alpha, Inc., a wholly owned subsidiary ...
    Recruiting
    Last update posted :
    05/10/2024
    Initiation :
    12/01/2022
    Primary completion :
    03/01/2025
    Completion :
    02/01/2026
    BCL2
    |
    azenosertib (ZN-c3) • asaretoclax (ZN-d5)
    Phase 1 First in Human Study of ZN-d5 as a Single Agent (NCT04500587)
    Phase 1
    K-Group Alpha, Inc., a wholly owned subsidiary ...
    Recruiting
    Last update posted :
    03/05/2024
    Initiation :
    10/13/2020
    Primary completion :
    08/02/2024
    Completion :
    01/01/2025
    BCL2
    |
    asaretoclax (ZN-d5)